Search results
Pfizer's Path To Profit: A Look At PFE Stock As Drugmaker Rolls Out $1.5B In Cost Reductions - ...
Benzinga· 3 days agoPfizer Inc. PFE has recently launched a multi-year cost reduction initiative aimed at saving...
Time to Pounce: 2 Ultra-High-Yield S&P 500 Dividend Stocks That Are Screaming Buys Right Now
Motley Fool via Yahoo Finance· 5 days agoThis is a 28% discount to its average forward-year multiple over the last five years, and one heck...
Billionaires Are Buying These High-Yield Dividend Stocks Left and Right. Should You Follow Their...
The Motley Fool via AOL· 7 days agoManagement predicts $4 billion in net cost savings by the end of 2024. In addition to lowered...
The West should be on a war footing for the next pandemic
The Telegraph via Yahoo News· 4 days agoPeople have been quick to forget how bad the pandemic was, but it’s important to remember the scale...
Century-old vaccine found to protect type 1 diabetics from infectious diseases
Medical Xpress· 4 days agoTwo back-to-back randomized double-blinded placebo-controlled trials found that the BCG vaccine provided continuous protection for nearly the entire COVID-19 pandemic in the ...
Uncover the Hidden Data on This Medical Procedure in Children
Mercola· 4 days ago“They do not publish the results [or] let any independent scientist in to look at that information,” Brian Hooker, chief scientific officer for Children’s Health Defense, said. In 1962, children received just five vaccine doses.
3 Blue-Chip Stocks Set to Triple Soon
InvestorPlace· 6 days agoInvestors should have a wide range of companies in multiple sectors within their investment portfolio. Companies with a strong reputation and...
6 Safe Blue Chip Dividend Stocks That Yield More Than Treasury Bonds
247wallst.com· 6 days agoSince 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital ...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 6 days agoAfter all, Moderna was not the behemoth it is today. Until 2020-end, the company lacked a marketed...
AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030
Fortune· 5 days agoThe company, which generated $45.8 billion in revenue last year, will launch 20 new medicines by the end of the decade to meet the new total revenue target, Astra said Tuesday. The revenue goal ...